MOTS-C

Price range: $75 through $100

5MG, 10MG, 20MG, 40MG

MOTS-c is dosed at 500 mcg–2 mg administered daily via subcutaneous injection in educational protocols. A 5 mg vial reconstituted with bacteriostatic water yields about 1.67 mg/mL. Most protocols titrate gradually over roughly 10 weeks. This information is for research and educational use only.

In stock   |   ≥99% catalog purity

SKU: N/A Categories: ,

Description

Product specification

Analytical Profile

Catalog data is presented for material identification and laboratory planning. Batch-specific documentation governs the supplied vial.

RESEARCH NAME MOST-C · LY3437943
FORMAT Lyophilised powder · 10 mg vial
MOLECULAR FORMULA C209H322N54O64
MOLECULAR MASS 4671.41 g/mol
CAS REGISTRY 2381089-83-2
ANALYTICAL IDENTITY HPLC + LC–MS
CATALOG CONDITION Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light; use within 2–4 weeks

PROTOCOL LITERACY

Reconstitution Sequence

This source-derived sequence assumes a 10 mg vial and a final reference volume of 1.0 mL. The supplied product documentation remains the controlling instruction.

01

Metabolic

Prepare 1.0 mL of bacteriostatic water with sterile equipment.

02

INTRODUCE SLOWLY

Direct the liquid toward the inside wall of the vial to limit foaming.

03

DISSOLVE GENTLY

Roll or swirl with care until the material is dissolved; do not shake.

04

LABEL AND PROTECT

Record the preparation date and keep the vial protected from light.

05

COLD STORAGE

Refrigerate at 2-8°C and use within the four-week reference window.

UNRECONSTITUTED MATERIAL

-20°C

Keep frozen, dry, sealed, and away from direct light. The supplied source describes stability for up to 24 months.

After reconstitution

2-8°C

Keep refrigerated and light-protected. Avoid repeated temperature cycling and follow batch documentation.

Handling principle

ONE THAW

If an approved study protocol requires frozen aliquots, avoid repeated freeze–thaw cycles.

PROTOCOL LITERACY

MOST-C DOSAGE CHART

A designed reference covering concentration, weekly schedule models, reconstitution, supply planning, storage, mechanism, study observations, and administration context. It is educational material—not an individualized regimen.

VIAL CONTENT

1.0 MG

+

REFERENCE DILUENT

1.0 MG

=

STOCK CONCENTRATION

1.0 MG/ML

U-100 SCALE

1 Unit = 0.01 ml 100 mcg

01

GRADUAL 8MG MODEL

02

12 MG TRIAL CONTEXT

EDUCATIONAL REFERENCE

GRADUAL 5MG MODEL

STUDY INTERVAL STAGE WEEKLY DOSE U-100 REFERENCE SOLUTION VOLUME
01 Weeks 1–2
INITIATION 5 MG 20 UNITS 0.20 ML
02 WEEKS 3-4
ESCALATION 01 10 MG 40 UNITS 0.40 ML
03 WEEKS 5-6
INITIATION 20 MG 60 UNITS 0.60 ML
04 WEEKS 7-8
UPPER REFERENCE 40 MG 80 UNITS 0.80 ML

01

REFERENCE ASSUMPTIONS

Every unit and volume value shown assumes a 10 mg vial prepared to a total reference volume of 1.0 mL.

02

MATERIAL BOUNDARY

This table does not provide preparation or administration instructions.

03

PROTOCOL CONTROL

Trial documentation and qualified clinical oversight—not this chart—must govern all dosing decisions.

Product Enquiry

Have a question about this product? Send us your enquiry and our team will get back to you shortly.

Enquire Product